Winter (Volume 28, Number 4)
Update from the ORA
By Henry Averns, MB, ChB, FRCP (UK), FRCPC
The Ontario Rheumatology Association (ORA) remains
highly active on behalf of its members, representing
the interests of rheumatologists and their patients
through ongoing meetings with multiple stakeholders. We
succeed thanks to the amazing engagement of our members.
We continue to work closely with the Ontario Public
Drug Program Exceptional Access Program (EAP) and private
payers to highlight areas important to our members.
We also developed a new biosimilar position statement on
the principles we would like to see attached to non-medical
switching, if imposed.
This year we also developed a revised governance structure
for the Board, and a Code of Conduct for our members.
Our manpower committee is planning on merging
with our emerging rheumatologists project, and plans include
a mentorship program and an event early in 2019 to
help young rheumatologists transition into practice, as well
as ongoing development of our “RheumCareers” website.
Our Annual Meeting was once again combined with an
Objective Structured Clinical Examination (OSCE) for the
trainees, and this is proving to be an annual highlight for
The Bill Bensen memorial fund has been accepting applications,
and we hope to announce successful recipients of
the first award soon.
We have almost completed a process for inviting external
IT developers to tender for our Informatics project.
By 2019, we believe we will have technology to produce
real-world evidence from the data within our electronic
medical records (EMRs) to inform our own practices and
develop comparative outcome data.
Henry Averns, MB, ChB, FRCP (UK), FRCPC
Ontartio Rheumatology Association